Science11 hours ago
Bayer Invests in KRAS Inhibitor; Treg Biotech Ceases Operations
The pharmaceutical landscape has seen significant developments this week, highlighted by Bayer’s substantial investment in a new KRAS inhibitor and the announcement of Treg Biotech’s closure....